Tacrolimus intrapatient variability in BK virus nephropathy and chronic calcineurin toxicity in kidney transplantation
Intrapatient variability (IPV) in tacrolimus has been increasingly acknowledged as a risk factor for poor graft survival after kidney transplantation. Although past studies have mainly accounted for IPV in acute or chronic rejection states as due to underimmunosuppression, this is not yet clear. So...
Main Authors: | Didem Turgut, Burak Sayin, Ebru Ayvazoglu Soy, Deniz İlhan Topcu, Binnaz Handan Ozdemir, Mehmet Haberal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2021;volume=32;issue=2;spage=348;epage=354;aulast=Turgut |
Similar Items
-
Number of Regularly Prescribed Drugs and Intrapatient Tacrolimus Trough Levels Variability in Stable Kidney Transplant Recipients
by: Piotr Giza, et al.
Published: (2020-06-01) -
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
by: Pere Fontova, et al.
Published: (2023-05-01) -
The calcineurin inhibitor tacrolimus specifically suppresses human T follicular helper cells
by: Wallin, E, et al.
Published: (2018) -
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients
by: Margherita Borriello, et al.
Published: (2022-07-01) -
Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol.
by: Goldsmith, PM, et al.
Published: (2017)